Methods, antibodies or antigen binding fragments and other tools for determining target molecules
AssigneeTeknologian tutkimuskeskus VTT Oy
InventorsTarja NEVANEN, Sirpa JYLHÄ, Henri AROLA
Life of this patent
Estimating the term…
Loading patent…
AssigneeTeknologian tutkimuskeskus VTT Oy
InventorsTarja NEVANEN, Sirpa JYLHÄ, Henri AROLA
Estimating the term…
The invention relates to a method for determining a target molecule in a sample. Also, the invention relates to a Förster resonance energy transfer (FRET, fluorescence resonance energy transfer) pair, recombinant antibodies, or antigen binding fragments thereof that bind Staphylococcus aureus Enterotoxin A and a test kit comprising the FRET pair, antibody or antigen binding fragment. Furthermore, the present invention relates to an isolated nucleic acid molecule comprising a nucleotide sequence that encodes the recombinant antibody or antigen binding fragment, and an expression vector comprising said nucleic acid molecule. Still, the invention relates to use of the FRET pair or the recombinant antibody or an antigen binding fragment thereof for determining a target molecule such as Staphylococcus aureus Enterotoxin A in a sample. And still, the invention relates to a method of producing the antibody or antigen binding fragment.
A method for determining a target molecule in a sample, wherein the method comprises:
A förster resonance energy transfer (FRET) pair comprising a first recombinant antibody or antigen binding fragment thereof that binds a target molecule and a second recombinant antibody or antigen binding fragment thereof that binds the target molecule at one or more different binding sites compared to the first recombinant antibody or antigen binding fragment thereof, wherein the target molecule is Staphylococcus aureus Enterotoxin A.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A recombinant antibody or antigen binding fragment thereof that binds Staphylococcus aureus Enterotoxin A, wherein the antibody or antigen binding fragment thereof comprises amino acids of one or more complementarity determining regions (CDRs) selected from the group consisting of
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
The test kit according to 29, wherein the antigen binding fragment of the first and/or second recombinant antibody is a single chain Fv (scFv) or Fab fragment.
Dependencies are inferred from the claim text.